TCP
LGND icon

TAMRO Capital Partners’s Ligand Pharmaceuticals LGND Stock Holding History

TAMRO Capital Partners’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-245,041
Closed -$7.18M – 111
2014
Q3 		$7.18M Sell
245,041
-239,418
-49% -$7.95M 0.48% 61
2014
Q2 		$18.8M Sell
484,459
-14,887
-3% -$604K 0.95% 50
2014
Q1 		$21M Buy
+499,346
New +$20.8M 0.91% 50

Other funds holding LGND

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAMRO Capital Partners's LGND Position: Q4 2014 in Review

TAMRO Capital Partners sold out of Ligand Pharmaceuticals (LGND) in Q4 2014, closing a stake of 245,041 shares — an estimated $7.18M sold.

TAMRO Capital Partners first reported a position in LGND in Q1 2014 and held it in 3 quarters. The position peaked at $21M in Q1 2014. 180 funds tracked by Wall St. Rank hold LGND as of Q4 2014.

  • TAMRO Capital Partners reported no remaining Ligand Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • TAMRO Capital Partners sold 245,041 Ligand Pharmaceuticals shares in Q4 2014, an estimated $7.18M.
  • TAMRO Capital Partners first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • TAMRO Capital Partners's Ligand Pharmaceuticals position peaked at $21M in Q1 2014.
  • 180 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2014.

Based on TAMRO Capital Partners's 13F filing for Q4 2014, filed 6 Feb 2015.